GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$108.52
—
Mkt Cap $4.66B
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
Implied Upside
-31.4%
Consensus $74.43 vs current $108.52
NASDAQ·Healthcare·Medical - Diagnostics & Research
$108.52
—
Mkt Cap $4.66B
Buy
3
Hold
2
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
-31.4%
Consensus $74.43 vs current $108.52